环丙沙星盐酸盐

环丙沙星盐酸盐用途

【用途一】
广谱抗菌类药，适用于重混合感染，主要用于慢性呼吸道、大肠杆菌药、传染性鼻炎、禽霍乱、禽伤寒等
【用途二】
该品是喹诺酮类抗菌药的优秀代表之一，由德国拜耳药厂于1983年研制成功，喹诺酮类抗菌药的第一代以萘啶酸为代表，第二代以吡哌酸为代表，第三代以氟哌酸为代表。环丙氟哌酸抗菌谱广、抗菌活性强，对革兰氏阳性菌和革兰氏阴性菌都有效，对绿脓杆菌也有效，不良反应少。是国际市场上销售额很大的药物品种，国内生产发展迅速。

环丙沙星盐酸盐名称

[ CAS 号 ]:
86483-48-9

[ 中文名 ]:
环丙氟哌酸盐酸盐

[ 英文名 ]:
Ciprofloxacin Hydrochloride

[中文别名 ]:

[英文别名 ]:

Ciprofloxacin base/HCL
Ciproxan
ciprofloxacine hydrochloride
MFCD00079044
CIPROFLOXACIN HCL HYDRATE
Ciflox
Ciprofloxacin Hydrochloride
CIPROFLOXACIN HYDROCHLORIDE MONOHYDRATE
ciprofloxacin monohydrochloride
Ciprofloxacin Hcl

环丙沙星盐酸盐物理化学性质

[ 沸点 ]:
581.8ºC at 760 mmHg

[ 熔点 ]:
>300 °C

[ 分子式 ]:
C₁₇H₁₉ClFN₃O₃

[ 分子量 ]:
367.802

[ 闪点 ]:
305.6ºC

[ 精确质量 ]:
367.109894

[ PSA ]:
74.57000

[ LogP ]:
2.77910

[ 外观性状 ]:
白色或淡黄色结晶粉末

[ 储存条件 ]:
室温，密闭，干燥

环丙沙星盐酸盐毒性和生态

CHEMICAL IDENTIFICATION

RTECS NUMBER :: VB1994000

CHEMICAL NAME :: 3-Quinolinecarboxylic acid, 1,4-dihydro-1-cyclopropyl-6-fluoro-4-oxo-7-(1-piperaz inyl)-, hydrochloride, hydrate

CAS REGISTRY NUMBER :: 86483-48-9

LAST UPDATED :: 199603

DATA ITEMS CITED :: 7

MOLECULAR FORMULA :: C17-H18-F-N3-O3.Cl-H.H2-O

MOLECULAR WEIGHT :: 385.86

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :: LD50 - Lethal dose, 50 percent kill

ROUTE OF EXPOSURE :: Oral

SPECIES OBSERVED :: Rodent - rat

DOSE/DURATION :: >5 gm/kg

TOXIC EFFECTS :: Details of toxic effects not reported other than lethal dose value

REFERENCE :: IYKEDH Iyakuhin Kenkyu. Study of Medical Supplies. (Nippon Koteisho Kyokai, 12-15, 2-chome, Shibuya, Shibuya-ku, Tokyo 150, Japan) V.1- 1970- Volume(issue)/page/year: 19,735,1988

TYPE OF TEST :: LD50 - Lethal dose, 50 percent kill

ROUTE OF EXPOSURE :: Intravenous

SPECIES OBSERVED :: Rodent - rat

DOSE/DURATION :: 300 mg/kg

TOXIC EFFECTS :: Details of toxic effects not reported other than lethal dose value

REFERENCE :: YKYUA6 Yakkyoku. Pharmacy. (Nanzando, 4-1-11, Yushima, Bunkyo-ku, Tokyo, Japan) V.1- 1950- Volume(issue)/page/year: 39,1752,1988

TYPE OF TEST :: LD50 - Lethal dose, 50 percent kill

ROUTE OF EXPOSURE :: Intramuscular

SPECIES OBSERVED :: Rodent - rat

DOSE/DURATION :: 300 mg/kg

TOXIC EFFECTS :: Details of toxic effects not reported other than lethal dose value

REFERENCE :: IYKEDH Iyakuhin Kenkyu. Study of Medical Supplies. (Nippon Koteisho Kyokai, 12-15, 2-chome, Shibuya, Shibuya-ku, Tokyo 150, Japan) V.1- 1970- Volume(issue)/page/year: 19,735,1988

TYPE OF TEST :: LD50 - Lethal dose, 50 percent kill

ROUTE OF EXPOSURE :: Oral

SPECIES OBSERVED :: Rodent - mouse

DOSE/DURATION :: >5 gm/kg

TOXIC EFFECTS :: Details of toxic effects not reported other than lethal dose value

REFERENCE :: IYKEDH Iyakuhin Kenkyu. Study of Medical Supplies. (Nippon Koteisho Kyokai, 12-15, 2-chome, Shibuya, Shibuya-ku, Tokyo 150, Japan) V.1- 1970- Volume(issue)/page/year: 19,735,1988

TYPE OF TEST :: LD50 - Lethal dose, 50 percent kill

ROUTE OF EXPOSURE :: Intravenous

SPECIES OBSERVED :: Rodent - mouse

DOSE/DURATION :: 258 mg/kg

TOXIC EFFECTS :: Details of toxic effects not reported other than lethal dose value

REFERENCE :: YKYUA6 Yakkyoku. Pharmacy. (Nanzando, 4-1-11, Yushima, Bunkyo-ku, Tokyo, Japan) V.1- 1950- Volume(issue)/page/year: 39,1752,1988

TYPE OF TEST :: LD50 - Lethal dose, 50 percent kill

ROUTE OF EXPOSURE :: Intramuscular

SPECIES OBSERVED :: Rodent - mouse

DOSE/DURATION :: 258 mg/kg

TOXIC EFFECTS :: Details of toxic effects not reported other than lethal dose value

REFERENCE :: IYKEDH Iyakuhin Kenkyu. Study of Medical Supplies. (Nippon Koteisho Kyokai, 12-15, 2-chome, Shibuya, Shibuya-ku, Tokyo 150, Japan) V.1- 1970- Volume(issue)/page/year: 19,735,1988

TYPE OF TEST :: LD50 - Lethal dose, 50 percent kill

ROUTE OF EXPOSURE :: Oral

SPECIES OBSERVED :: Primate - monkey

DOSE/DURATION :: >5 gm/kg

TOXIC EFFECTS :: Details of toxic effects not reported other than lethal dose value

REFERENCE :: JZKEDZ Jitchuken Zenrinsho Kenkyuho. Central Institute for Experimental Animals, Research Reports. (Jikken Dobutsu Chuo Kenkyusho, 1433 Nogawa, Takatsu-ku, Kawasaki 211, Japan) V.1- 1975- Volume(issue)/page/year: 11,411,1985

环丙沙星盐酸盐安全信息

[ 危害码 (欧洲) ]:
Xi:Irritant

[ 风险声明 (欧洲) ]:
R36/37/38

[ 安全声明 (欧洲) ]:
S26-S36

[ WGK德国 ]:
3

[ 海关编码 ]:
29419000

环丙沙星盐酸盐制备

将3-氯-4-氟苯胺重氮化、置换，生成2,4-二氯氟苯，再经乙酰化得到2,4-二氯-5-氟苯乙酮，将其与碳酸二乙酯缩合制备2,4-二氯-5-氟苯甲酰乙酸乙酯，然后与原甲酸三乙酯、乙酸酐、环丙胺分步反应制成2-（3,4-二氯-5-氟苯甲酰）-3-环丙胺基丙烯酸乙酯，后者与NaH在无水二噁烷中反应，回流2h，生成1-环丙基-7-氯-6-氟-1,4-二氢-4-氧代喹啉-3-羧酸，最后与水哌嗪反应得到环丙哌酸

环丙沙星盐酸盐海关

[ 海关编码 ]: 2933491000

[ 中文概述 ]:
2933491000. 环丙氟哌酸. 增值税率:17.0%. 退税率:9.0%. 监管条件:无. 最低关税:6.5%. 普通关税:20.0%

[ 申报要素 ]: 品名, 成分含量, 用途, 乌洛托品请注明外观, 6－己内酰胺请注明外观, 签约日期

[ Summary ]:
2933491000. VAT:17.0%. Tax rebate rate:9.0%. . MFN tariff:6.5%. General tariff:20.0%

环丙沙星盐酸盐相关知识

盐酸环丙沙星片说明书-盐酸环丙沙星副作用

2019-01-09 16:22:00

导读：盐酸环丙沙星片对需氧革兰阴性杆菌的抗菌活性高，对下列细菌在体外具良好抗菌作用：肠杆菌科的大部分细菌，包括枸椽酸杆菌属、阴沟、产气肠杆菌、大肠埃希菌、克雷伯菌属、弧菌属、耶尔森菌等。在使用的时候需要注意盐酸环丙沙星能抑制茶碱的正常代谢,联合应用可引起茶碱的严重不良反应;可与食物同服，但抗酸药则...